BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 36635177)

  • 1. Brain Serotonin Release Is Reduced in Patients With Depression: A [
    Erritzoe D; Godlewska BR; Rizzo G; Searle GE; Agnorelli C; Lewis Y; Ashok AH; Colasanti A; Boura I; Farrell C; Parfitt H; Howes O; Passchier J; Gunn RN; Politis M; Nutt DJ; Cowen PJ; Knudsen GM; Rabiner EA
    Biol Psychiatry; 2023 Jun; 93(12):1089-1098. PubMed ID: 36635177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serotonin release measured in the human brain: a PET study with [
    Erritzoe D; Ashok AH; Searle GE; Colasanti A; Turton S; Lewis Y; Huiban M; Moz S; Passchier J; Saleem A; Beaver J; Lingford-Hughes A; Nutt DJ; Howes OD; Gunn RN; Knudsen GM; Rabiner EA
    Neuropsychopharmacology; 2020 Apr; 45(5):804-810. PubMed ID: 31715617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of [(11)C]Cimbi-36 as an agonist PET radioligand for the 5-HT(2A) and 5-HT(2C) receptors in the nonhuman primate brain.
    Finnema SJ; Stepanov V; Ettrup A; Nakao R; Amini N; Svedberg M; Lehmann C; Hansen M; Knudsen GM; Halldin C
    Neuroimage; 2014 Jan; 84():342-53. PubMed ID: 23994452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serotonin 2A receptor agonist binding in the human brain with [¹¹C]Cimbi-36.
    Ettrup A; da Cunha-Bang S; McMahon B; Lehel S; Dyssegaard A; Skibsted AW; Jørgensen LM; Hansen M; Baandrup AO; Bache S; Svarer C; Kristensen JL; Gillings N; Madsen J; Knudsen GM
    J Cereb Blood Flow Metab; 2014 Jul; 34(7):1188-96. PubMed ID: 24780897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiosynthesis and evaluation of 11C-CIMBI-5 as a 5-HT2A receptor agonist radioligand for PET.
    Ettrup A; Palner M; Gillings N; Santini MA; Hansen M; Kornum BR; Rasmussen LK; Någren K; Madsen J; Begtrup M; Knudsen GM
    J Nucl Med; 2010 Nov; 51(11):1763-70. PubMed ID: 20956470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brain serotonin transporter binding potential measured with carbon 11-labeled DASB positron emission tomography: effects of major depressive episodes and severity of dysfunctional attitudes.
    Meyer JH; Houle S; Sagrati S; Carella A; Hussey DF; Ginovart N; Goulding V; Kennedy J; Wilson AA
    Arch Gen Psychiatry; 2004 Dec; 61(12):1271-9. PubMed ID: 15583118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cerebral 5-HT release correlates with [
    Jørgensen LM; Weikop P; Villadsen J; Visnapuu T; Ettrup A; Hansen HD; Baandrup AO; Andersen FL; Bjarkam CR; Thomsen C; Jespersen B; Knudsen GM
    J Cereb Blood Flow Metab; 2017 Feb; 37(2):425-434. PubMed ID: 26825776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiosynthesis and in vivo evaluation of a series of substituted 11C-phenethylamines as 5-HT (2A) agonist PET tracers.
    Ettrup A; Hansen M; Santini MA; Paine J; Gillings N; Palner M; Lehel S; Herth MM; Madsen J; Kristensen J; Begtrup M; Knudsen GM
    Eur J Nucl Med Mol Imaging; 2011 Apr; 38(4):681-93. PubMed ID: 21174090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serotonin 2A receptor agonist binding in the human brain with [(11)C]Cimbi-36: Test-retest reproducibility and head-to-head comparison with the antagonist [(18)F]altanserin.
    Ettrup A; Svarer C; McMahon B; da Cunha-Bang S; Lehel S; Møller K; Dyssegaard A; Ganz M; Beliveau V; Jørgensen LM; Gillings N; Knudsen GM
    Neuroimage; 2016 Apr; 130():167-174. PubMed ID: 26876490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dopamine Release in Antidepressant-Naive Major Depressive Disorder: A Multimodal [
    Schneier FR; Slifstein M; Whitton AE; Pizzagalli DA; Reinen J; McGrath PJ; Iosifescu DV; Abi-Dargham A
    Biol Psychiatry; 2018 Oct; 84(8):563-573. PubMed ID: 30041971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fenfluramine Reduces [11C]Cimbi-36 Binding to the 5-HT2A Receptor in the Nonhuman Primate Brain.
    Yang KC; Stepanov V; Martinsson S; Ettrup A; Takano A; Knudsen GM; Halldin C; Farde L; Finnema SJ
    Int J Neuropsychopharmacol; 2017 Sep; 20(9):683-691. PubMed ID: 28911007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo 5-HT
    Radhakrishnan R; Matuskey D; Nabulsi N; Gaiser E; Gallezot JD; Henry S; Planeta B; Lin SF; Ropchan J; Huang Y; Carson RE; D'Souza DC
    Psychiatry Res Neuroimaging; 2020 Jan; 295():111007. PubMed ID: 31760336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cortical and subcortical 5-HT2A receptor binding in neuroleptic-naive first-episode schizophrenic patients.
    Erritzoe D; Rasmussen H; Kristiansen KT; Frokjaer VG; Haugbol S; Pinborg L; Baaré W; Svarer C; Madsen J; Lublin H; Knudsen GM; Glenthoj BY
    Neuropsychopharmacology; 2008 Sep; 33(10):2435-41. PubMed ID: 18288096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased 5-HT(2A) receptor binding in euthymic, medication-free patients recovered from depression: a positron emission study with [(11)C]MDL 100,907.
    Bhagwagar Z; Hinz R; Taylor M; Fancy S; Cowen P; Grasby P
    Am J Psychiatry; 2006 Sep; 163(9):1580-7. PubMed ID: 16946184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trait Openness and serotonin 2A receptors in healthy volunteers: A positron emission tomography study.
    Stenbaek DS; Kristiansen S; Burmester D; Madsen MK; Frokjaer VG; Knudsen GM; Fisher PM
    Hum Brain Mapp; 2019 May; 40(7):2117-2124. PubMed ID: 30633430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased hippocampal 5-HT2A receptor binding in major depressive disorder: in vivo measurement with [18F]altanserin positron emission tomography.
    Mintun MA; Sheline YI; Moerlein SM; Vlassenko AG; Huang Y; Snyder AZ
    Biol Psychiatry; 2004 Feb; 55(3):217-24. PubMed ID: 14744461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serotonin 2A receptors in obsessive-compulsive disorder: a positron emission tomography study with [11C]MDL 100907.
    Simpson HB; Slifstein M; Bender J; Xu X; Hackett E; Maher MJ; Abi-Dargham A
    Biol Psychiatry; 2011 Nov; 70(9):897-904. PubMed ID: 21855857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo PET study of 5HT(2A) serotonin and D(2) dopamine dysfunction in drug-naive obsessive-compulsive disorder.
    Perani D; Garibotto V; Gorini A; Moresco RM; Henin M; Panzacchi A; Matarrese M; Carpinelli A; Bellodi L; Fazio F
    Neuroimage; 2008 Aug; 42(1):306-14. PubMed ID: 18511303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Active cyamemazine metabolites in patients treated with cyamemazine (Tercian®): influence on cerebral dopamine D2 and serotonin 5-HT (2A) receptor occupancy as measured by positron emission tomography (PET).
    Hodé Y; Benyamina A; Arbus C; Reimold M
    Psychopharmacology (Berl); 2011 Oct; 217(3):315-21. PubMed ID: 21479533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serotonergic Neurotransmission in Limbic Regions May Reflect Therapeutic Response of Depressive Patients: A PET Study With 11C-WAY-100635 and 18F-MPPF.
    Kitamura S; Kimura Y; Takahata K; Moriguchi S; Kubota M; Shimada H; Endo H; Takado Y; Kawamura K; Zhang MR; Suhara T; Higuchi M
    Int J Neuropsychopharmacol; 2023 Jul; 26(7):474-482. PubMed ID: 37279545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.